APOE and Mental deterioration: In the Arizona APOE cohort (n = 815) with mean age of participants at baseline being 60.1 years and mean follow-up 5 years, ε4 homozygous had a more pronounced cognitive decline than ε4 non-carriers but no significant difference was observed for ε4 heterozygotes [14].